Harvest Fund Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386K | Buy |
1,303
+34
| +3% | +$10.1K | 0.02% | 269 |
|
|
2025
Q1 | $379K | Buy |
1,269
+357
| +39% | +$107K | 0.02% | 306 |
|
|
2024
Q4 | $299K | Buy |
+912
| New | +$299K | 0.01% | 411 |
|
|
2024
Q2 | – | Sell |
-781
| Closed | -$309K | – | 775 |
|
|
2024
Q1 | $309K | Buy |
781
+426
| +120% | +$169K | 0.03% | 260 |
|
|
2023
Q4 | $125K | Sell |
355
-325
| -48% | -$114K | 0.02% | 293 |
|
|
2023
Q3 | $255K | Sell |
680
-244
| -26% | -$91.5K | 0.04% | 187 |
|
|
2023
Q2 | $353K | Buy |
924
+498
| +117% | +$190K | 0.07% | 136 |
|
|
2023
Q1 | $148K | Buy |
426
+189
| +80% | +$65.7K | 0.03% | 255 |
|
|
2022
Q4 | $56K | Sell |
237
-534
| -69% | -$126K | 0.01% | 454 |
|
|
2022
Q3 | $190K | Hold |
771
| – | – | 0.06% | 196 |
|
|
2022
Q2 | $233K | Sell |
771
-312
| -29% | -$94.3K | 0.06% | 142 |
|
|
2022
Q1 | $444K | Sell |
1,083
-632
| -37% | -$259K | 0.09% | 103 |
|
|
2021
Q4 | $806K | Buy |
1,715
+499
| +41% | +$235K | 0.14% | 60 |
|
|
2021
Q3 | $516K | Buy |
1,216
+320
| +36% | +$136K | 0.12% | 61 |
|
|
2021
Q2 | $322K | Hold |
896
| – | – | 0.03% | 97 |
|
|
2021
Q1 | $252K | Sell |
896
-232
| -21% | -$65.3K | 0.02% | 119 |
|
|
2020
Q4 | $319K | Sell |
1,128
-676
| -37% | -$191K | 0.03% | 100 |
|
|
2020
Q3 | $518K | Buy |
1,804
+841
| +87% | +$241K | 0.04% | 84 |
|
|
2020
Q2 | $216K | Sell |
963
-131
| -12% | -$29.4K | 0.02% | 136 |
|
|
2020
Q1 | $167K | Buy |
1,094
+599
| +121% | +$91.4K | 0.02% | 140 |
|
|
2019
Q4 | $78K | Hold |
495
| – | – | 0.01% | 231 |
|
|
2019
Q3 | $70K | Buy |
+495
| New | +$70K | 0.01% | 235 |
|
|
2018
Q4 | – | Sell |
-407
| Closed | -$50K | – | 468 |
|
|
2018
Q3 | $50K | Buy |
+407
| New | +$50K | 0.01% | 363 |
|